Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 3/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.42 |
| ▸ | OR51E2 | Q9H255 | 1/20 | 0.42 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.42 |
| ▸ | TSHR | P16473 | 3/20 | 0.40 |
| ▸ | PGD | P52209 | 1/20 | 0.40 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.39 |
| ▸ | ACHE | P22303 | 1/20 | 0.39 |
| ▸ | BLM | P54132 | 2/20 | 0.36 |
| ▸ | PMP22 | Q01453 | 2/20 | 0.36 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.36 |
| ▸ | LDHA | P00338 | 1/20 | 0.33 |
| ▸ | LDHB | P07195 | 1/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.31 |
| ▸ | NFKB1 | P19838 | 2/20 | 0.31 |
| ▸ | HPGD | P15428 | 1/20 | 0.31 |
| ▸ | EHMT2 | Q96KQ7 | 1/20 | 0.31 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.31 |
| ▸ | EHMT1 | Q9H9B1 | 1/20 | 0.31 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7093505 | 1.00 | LMNA (0.42) | LMNAALDH1A1OR51E2TDP1TSHR | |
| SCHEMBL77247 | 1.00 | LMNA (0.42) | LMNAALDH1A1OR51E2TDP1TSHR | |
| SCHEMBL698993 | 0.86 | TSHR (0.67) | LMNAALDH1A1OR51E2TDP1TSHR | |
| SCHEMBL1000048 | 0.84 | PGD (0.37) | LMNAALDH1A1OR51E2TDP1TSHR | |
| SCHEMBL18902784 | 0.84 | PGD (0.37) | LMNAALDH1A1OR51E2TDP1TSHR | |
| SCHEMBL987602 | 0.84 | PGD (0.37) | LMNAALDH1A1OR51E2TDP1TSHR | |
| SCHEMBL4449219 | 0.84 | PGD (0.37) | LMNAALDH1A1OR51E2TDP1TSHR | |
| SCHEMBL6686437 | 0.84 | PGD (0.37) | LMNAALDH1A1OR51E2TDP1TSHR | |
| SCHEMBL18902700 | 0.83 | PGD (0.33) | LMNATSHRPGDHIF1ABLM | |
| SCHEMBL18902557 | 0.83 | LMNA (0.41) | LMNATDP1TSHRPGDHIF1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12127571-B2 | Particulate acidulant composition comprising malic acid and lactic acid | PURAC BIOCHEM B.V. (NL) | 2024-10-29 | — | — | US | disclosed |
| CN-110743622-B | Montmorillonite immobilized chiral compound and preparation method thereof | 西安石油大学 | 2022-07-12 | — | — | CN | disclosed |
| EP-2116526-B1 | DERIVATES OF SUBSTITUTED TARTARIC AICD AND USAGE FOR PREPARATING BETA SECRETASE INHIBITORS | INST PHARMACOLOGY & TOXICOLOGY ACADEMY MILITARY MEDICAL SCIENCES PLA CHINA (CN) | 2018-04-18 | — | — | EP | disclosed |
| WO-2015195563-A1 | ANTIBACTERIAL AGENTS | RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY (US) | 2015-12-23 | — | — | WO | disclosed |
| US-8258345-B2 | Hydroxylation of β-dicarbonyls with zirconium catalysts | E I DU PONT DE NEMOURS AND COMPANY (US) | 2012-09-04 | — | — | US | disclosed |
| US-20110196175-A1 | Hydroxylation of Beta-Dicarbonyls with Zirconium Catalysts | FMC CORPORATION | 2011-08-11 | — | — | US | disclosed |
| US-7939685-B2 | Hydroxylation of β-dicarbonyls with zirconium catalysts | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2011-05-10 | — | — | US | disclosed |
| US-20100185014-A1 | Hydroxylation of Beta-Dicarbonyls with Zirconium Catalysts | FMC CORPORATION | 2010-07-22 | — | — | US | disclosed |
| US-7718818-B2 | Hydroxylation of beta-dicarbonyls with zirconium catalysts | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 2010-05-18 | — | — | US | disclosed |
| US-20080306259-A1 | HYDROXYLATION OF BETA-DICARBONYLS WITH ZIRCONIUM CATALYSTS | FMC CORPORATION | 2008-12-11 | — | — | US | disclosed |
| US-7414157-B2 | Hydroxylation of β-dicarbonyls with zirconium catalysts | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2008-08-19 | — | — | US | disclosed |
| US-7169544-B2 | Thermally developable materials containing thermal solvents | EASTMAN KODAK COMPANY (US) | 2007-01-30 | — | — | US | disclosed |
| EP-1401575-B1 | HYDROXYLATION OF BETA-DICARBONYLS WITH ZIRCONIUM CATALYSTS | DU PONT (US) | 2007-01-17 | — | — | EP | disclosed |
| US-20040143123-A1 | Hydroxylation of beta-dicarbonyls with zirconium catalysts | FMC CORPORATION | 2004-07-22 | — | — | US | disclosed |
| EP-1401575-A1 | HYDROXYLATION OF BETA-DICARBONYLS WITH ZIRCONIUM CATALYSTS | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 2004-03-31 | — | — | EP | disclosed |
| WO-2003002255-A1 | HYDROXYLATION OF BETA-DICARBONYLS WITH ZIRCONIUM CATALYSTS | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 2003-01-09 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100185014-A1 | Hydroxylation of Beta-Dicarbonyls with Zirconium Catalysts | CBR3, CBR1, NOXO1 | LMNA 3105/4885ALDH1A1 258/4885OR51E2 1371/4885 |
| US-20040143123-A1 | Hydroxylation of beta-dicarbonyls with zirconium catalysts | CBR1, CBR3, NOXO1 | LMNA 3661/4885ALDH1A1 163/4885OR51E2 1879/4885 |
| US-20110196175-A1 | Hydroxylation of Beta-Dicarbonyls with Zirconium Catalysts | CBR3, CBR1, NOXO1 | LMNA 3105/4885ALDH1A1 258/4885OR51E2 1371/4885 |
| US-20080306259-A1 | HYDROXYLATION OF BETA-DICARBONYLS WITH ZIRCONIUM CATALYSTS | CBR3, CBR1, ASPH | LMNA 3881/4885ALDH1A1 260/4885OR51E2 809/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.